|
|
||||||||


*
Department of Immunology, National Institutes of Health, Tokyo, Japan;
Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan; and
Biochemical Research Laboratory, Morinaga Milk Industry Co., Ltd., Kanagawa, Japan
We previously demonstrated that IL-10 alone does not
stimulate growth and differentiation of human monocytes, but enhances
those of monocytes stimulated with M-CSF. We studied here the effect of
IL-10 on human monocytes stimulated with GM-CSF. Monocytes stimulated
with GM-CSF alone survived and developed into macrophages. Monocytes
cultured with GM-CSF plus IL-10, however, died through apoptosis. IL-10
decreased expression of bcl-2, bcl-xL, and mcl-1- but not
bax mRNA in monocytes stimulated with GM-CSF. IL-10 did not change the
expression of mRNA of both GM-CSFR
-chain and
-chain, but
inhibited tyrosine phosphorylation of STAT5 and extracellular
signal-regulated kinases 1 and 2 in the monocytes. The inhibitory
effect of IL-10 was restricted to treatment 48 h after stimulation
with GM-CSF. Addition of IL-10 after that time induced neither
apoptosis nor a decrease in expression of bcl-2, bcl-xL,
and mcl-1 mRNA. IL-10, however, inhibited LPS-induced TNF-
production even in these cells, indicating that the cells still
possessed responsiveness to IL-10. Monocytes pretreated for >48 h with
GM-CSF became resistant to GM-CSF withdrawal, and the cells could
survive without GM-CSF. These results indicate that IL-10 selectively
inhibits GM-CSF-dependent monocyte survival by inhibiting the signaling
events induced by GM-CSF, but the timing of addition of IL-10 is
critical, and IL-10 had to be added within 48 h after stimulation
with GM-CSF to achieve the inhibitory effect. These results taken
together with our previous results indicate that IL-10 plays a pivotal
role in monocyte survival and development into macrophages in concert
with M-CSF and GM-CSF.
This article has been cited by other articles:
![]() |
S. W. Waldo, Y. Li, C. Buono, B. Zhao, E. M. Billings, J. Chang, and H. S. Kruth Heterogeneity of Human Macrophages in Culture and in Atherosclerotic Plaques Am. J. Pathol., April 1, 2008; 172(4): 1112 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lombardo, A. Alvarez-Barrientos, B. Maroto, L. Bosca, and U. G. Knaus TLR4-Mediated Survival of Macrophages Is MyD88 Dependent and Requires TNF-{alpha} Autocrine Signalling J. Immunol., March 15, 2007; 178(6): 3731 - 3739. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Komuro, T. Yasuda, A. Iwamoto, and K. S. Akagawa Catalase Plays a Critical Role in the CSF-independent Survival of Human Macrophages via Regulation of the Expression of BCL-2 Family J. Biol. Chem., December 16, 2005; 280(50): 41137 - 41145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xue, S. L. Gyles, F. R. Wettey, L. Gazi, E. Townsend, M. G. Hunter, and R. Pettipher Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells J. Immunol., November 15, 2005; 175(10): 6531 - 6536. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halvorsen, T. Waehre, H. Scholz, O. P. Clausen, J. H. von der Thusen, F. Muller, H. Heimli, S. Tonstad, C. Hall, S. S. Froland, et al. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms J. Lipid Res., February 1, 2005; 46(2): 211 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Natelson, S. A. Weaver, C.-L. Tseng, and J. E. Ottenweller Spinal Fluid Abnormalities in Patients with Chronic Fatigue Syndrome Clin. Vaccine Immunol., January 1, 2005; 12(1): 52 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Komuro, Y. Yokota, S. Yasuda, A. Iwamoto, and K. S. Kagawa CSF-induced and HIV-1-mediated Distinct Regulation of Hck and C/EBP{beta} Represent a Heterogeneous Susceptibility of Monocyte-derived Macrophages to M-tropic HIV-1 Infection J. Exp. Med., August 4, 2003; 198(3): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |